1Leung M,Zhang Y,Differentialstrutural requirement for sepecific binding of nonpeptide and peptide antagonist to theAT1 angiotentin receptor;identification of amino acid residues that determine binding ofthe antihypertention drug losartan.J Biol Chem.1994,269(24):16533-16536.
3Carla Zoja,Biolscid,Roberfa DD,et al.The renoprotective properties ofangiotentin-converting enzyme inhibitors in a chronic model of membranous nephropathy aresolely due to the inhibition of angiotentin II:evidence based on comparative studies witha receptors antagonist.AJKD,1997,29(2):254-264
4Hatch M,Fred RW,Shahinfar S,et al.Effects of the specific angiotensin II receptorantagonist losartan on urate homeostasis and intestinal urate transport.J Pharmocol ExpTher,1996,276(1):187-193
